Anastasia Yemelyanova

Anastasia Yemelyanova

Company: Spark Therapeutics

Job title: Director of Regulatory CMC


Exploring Different Approaches & Expectations in Proving Comparability in a Global Setting 10:00 am

Clarifying the FDA Expectations on Repeat Studies for Non-Clinical Studies Between and Before Phase 3 Exploring Different Global Approaches to Comparability between the FDA, EMA and other Regulatory Bodies Understanding the Depth and Timelines Needed for Comparability Data as Gene Therapy Programs progress to phase 1 and 2 When Resource Burden IncreasesRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.